CLINICAL_TRIALS
trial_result
· 2019-06-26
Clinical Trial Update: Study of Secukinumab With 2 mL Pre-filled Syringes [Phase 3]
Summary
Phase 3 trial of secukinumab using 2 mL pre-filled syringes in psoriasis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-06-26